Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Allopurinol, benzbromarone, and probenecid efficacy and tolerability in gout
NL-OMON25101Active, not recruiting
- Sponsor
- Medisch Centrum Leeuwarden
- Start
- Jun 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial in gout and hyperuricemia comparing Stage 1 allopurinol, Stage 2 benzbromarone and Stage 2 probenecid (3 arms). Started Jun 2005; status: active, not recruiting.
02
Drugs
allopurinolbenzbromaroneprobenecid
03
Conditions
gouthyperuricemia
Beyond the preview
Go deeper on NL-OMON25101.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON25101.